Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SubTerra is a biotechnology company specializing in the production of plant-derived pharmaceuticals through a process known as molecular farming. The company operates a unique manufacturing facility located 1,200 feet underground in a former copper mine in White Pine, Michigan. This subterranean environment provides a naturally stable climate and high levels of biosecurity, shielding pharmaceutical crops from external pathogens and environmental fluctuations. SubTerra's platform utilizes genetically modified plants to express complex recombinant proteins, including vaccines and therapeutic enzymes. By leveraging controlled environment agriculture in an isolated setting, the company aims to provide a scalable and cost-effective alternative to traditional bioreactor-based protein production. Their services are primarily geared toward contract manufacturing for the pharmaceutical and biodefense industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SubTerra.